NTRA Nasdaq 2020 - 10 - 05

Natera, Inc.

NTRA | News M | $92.61 1.73% 140K

(0.0% 1d) (-0.4% 1m) (79.6% 1y) (0.0% 2d) (2.7% 3d) (6.8% 7d) (5.13% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 11,183,386,989
http://www.natera.com
Sec Filling | Patents | 1039 employees

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

genetic diagnostics

add to watch list Paper trade email alert is off

Press-releases

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| 6.75% | O: 1.38% H: 3.26% C: 2.49%
milestone

Liberty All-Star® Growth Fund, Inc. March 2024 Monthly Update
Published: 2024-04-12 (Crawled : 00:20) - prnewswire.com
AMZN S | $177.64 -1.06% 10M

Retail Trade

| Email alert Add to watchlist
CWST | $94.64 -0.83% 48K

Industrial Services

| Email alert Add to watchlist
NTRA | News M | $92.61 1.73% 140K

Health Services

| Email alert Add to watchlist
PGNY | $32.23 -0.53% 160K

Commercial Services

| Email alert Add to watchlist
SPSC | $171.88 0.75% 35K

Technology Services

| Email alert Add to watchlist
TRNS | $113.04 -1.69% 6K

Electronic Technology

| Email alert Add to watchlist
VERX | News | $28.56 2.22% 3.5M

Technology Services

| Email alert Add to watchlist
CR | $142.37 3.08% 100K

Producer Manufacturing

| Email alert Add to watchlist
EME | $339.57 0.44% 96K

Industrial Services

| Email alert Add to watchlist
SITE | $163.24 0.36% 34K

Distribution Services

| Email alert Add to watchlist
star update liberty growth

Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
Published: 2024-04-11 (Crawled : 00:00) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| -5.66% | O: -0.36% H: 0.0% C: 0.0%
kidney publication study

Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| -5.9% | O: 0.92% H: 0.26% C: -2.26%
test for heart

Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published: 2024-04-05 (Crawled : 12:30) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| -1.75% | O: 2.12% H: 4.35% C: 2.25%
bladder positive cancer trial

Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| -0.46% | O: -0.6% H: 2.8% C: 2.25%
cancer trials trial

Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
Published: 2024-03-18 (Crawled : 12:30) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| 1.7% | O: 0.19% H: 1.46% C: 0.48%
cancer trial

Natera to Present New Data at the 2024 SGO Annual Meeting on Women’s Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| 1.97% | O: 0.07% H: 1.68% C: 1.65%
breast meeting

Natera to Participate in March Investor Conferences
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| 18.93% | O: 11.99% H: 5.68% C: 0.89%

Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
Published: 2024-02-20 (Crawled : 14:00) - biospace.com/
NTRA | News M | $92.61 1.73% 140K

Health Services

| 30.04% | O: -1.86% H: 2.81% C: 2.47%
conference

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-011407	4	2024-04-24	2024-04-21	Sell	M	143	430
0001415889-24-011407	4	2024-04-24	2024-04-20	Sell	M	190	1332
0001415889-24-011407	4	2024-04-24	2024-04-21	Buy	M	143	321364
0001415889-24-011407	4	2024-04-24	2024-04-20	Buy	M	190	321221
0001415889-24-011406	4	2024-04-24	2024-04-21	Sell	M	644	1932
0001415889-24-011406	4	2024-04-24	2024-04-20	Sell	M	856	5992
0001415889-24-011406	4	2024-04-24	2024-04-23	Sell	S	787	205552
0001415889-24-011406	4	2024-04-24	2024-04-21	Buy	M	644	206339
0001415889-24-011406	4	2024-04-24	2024-04-20	Buy	M	856	205695
0001415889-24-011405	4	2024-04-24	2024-04-23	Sell	S	531	117029
0001415889-24-011404	4	2024-04-24	2024-04-23	Sell	S	522	111677
0001415889-24-011403	4	2024-04-24	2024-04-21	Sell	M	1775	5324
0001415889-24-011403	4	2024-04-24	2024-04-20	Sell	M	3386	23702
0001415889-24-011403	4	2024-04-24	2024-04-23	Sell	S	2552	230319
0001415889-24-011403	4	2024-04-24	2024-04-21	Buy	M	1775	232871
0001415889-24-011403	4	2024-04-24	2024-04-20	Buy	M	3386	231096